Biotech · Public company · New York, NY, US

MeiraGTx Holdings plc

Ticker MGTX · SEC CIK 0001735438

Track this companyFree. Adds MeiraGTx Holdings plc to your Dealase workspace and tells you when its record changes.

Clinical trials64 recruiting or active

Pipeline programs10From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline10

AAV-GADPhase 2 · Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
AAV-GAD High DosePhase 2 · Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
AAV-GAD Low DosePhase 2 · Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
AAV2-hAQP1Phase 2 · Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid GlandsClinicalTrials.gov · fetched Nov 12, 2026
AAV2-hAQP1 Concentration 1Phase 2 · Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid GlandsClinicalTrials.gov · fetched Nov 12, 2026
AAV2-hAQP1 Concentration 2Phase 2 · Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid GlandsClinicalTrials.gov · fetched Nov 12, 2026
AAV2-hAQP1 Concentration 3Phase 2 · Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid GlandsClinicalTrials.gov · fetched Nov 12, 2026
AAV2-hAQP1 Concentration 4Phase 2 · Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid GlandsClinicalTrials.gov · fetched Nov 12, 2026
Sham SurgeryPhase 2 · Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
AAV2hAQP1Phase 1 · Squamous Cell Head and Neck CancerClinicalTrials.gov · fetched Nov 12, 2026

Long-term Follow-up of Gene Therapy for Radiation-Induced XerostomiaPHASE2 · ENROLLING_BY_INVITATION · started Aug 2, 2024ClinicalTrials.gov NCT06544798 · fetched Nov 12, 2026
A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late XerostomiaPHASE2 · ACTIVE_NOT_RECRUITING · started Jun 13, 2023ClinicalTrials.gov NCT05926765 · fetched Nov 12, 2026
Long-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's DiseasePHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started May 19, 2023ClinicalTrials.gov NCT05894343 · fetched Nov 12, 2026
A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's ParticipantsPHASE1_PHASE2 · COMPLETED · started Oct 5, 2022ClinicalTrials.gov NCT05603312 · fetched Nov 12, 2026
Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced XerostomiaACTIVE_NOT_RECRUITING · started Nov 12, 2020ClinicalTrials.gov NCT05060341 · fetched Nov 12, 2026
Safety of a Single Administration of AAV2hAQP1, an Adeno-Associated Viral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in People With Irradiation-Induced Parotid Salivary HypofunctionPHASE1 · COMPLETED · started May 4, 2015ClinicalTrials.gov NCT02446249 · fetched Nov 12, 2026